Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice.
Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts2Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, B.
Samia
S
Mora
Software and Mobile Application Development, Boston, Massachusetts.
Jeffrey M
JM
Ames
Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts4Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
JoAnn E
JE
Manson
D000367:Age Factors; D000368:Aged; D000465:Algorithms; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002423:Cause of Death; D015179:Colorectal Neoplasms / Q000517:prevention & control; D003657:Decision Making; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D061366:Numbers Needed To Treat; D010437:Peptic Ulcer / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D057285:Precision Medicine; D011322:Primary Prevention / Q000379:methods*; D018570:Risk Assessment
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin